Primary prevention of childhood asthma and allergic disorders

Moira Chan-Yeung1, Allan Becker

  • 1Occupational and Environmental Lung Diseases Unit, Respiratory Division, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada. myeung@interchange.ubc.ca

Insights

Primary prevention of childhood asthma and allergies is complex. Multifaceted interventions reducing allergen exposure show promise, but more research is needed on long-term effects and novel strategies.

Area of Science:

  • Pediatric Allergy and Immunology
  • Environmental Health
  • Preventive Medicine

Background:

  • Childhood asthma and allergic disorders are increasing globally.
  • Environmental factors play a significant role in disease development.
  • Primary prevention strategies are crucial.

Purpose of the Study:

  • To review recent findings on environmental risk factors for childhood asthma and allergies.
  • To examine the manipulation of these factors for primary prevention.
  • To address controversies and emerging evidence in the field.

Main Methods:

  • Review of recent scientific literature on environmental risk factors and interventions.
  • Analysis of studies on indoor aeroallergens, viral infections, and breastfeeding.
  • Evaluation of multifaceted intervention trials and other preventive measures.

Main Results:

  • Controversy persists regarding indoor aeroallergen exposure and asthma risk.
  • Infant bronchiolitis (RSV) increases asthma risk, but not atopy.
  • Breastfeeding effects are debated; multifaceted allergen reduction interventions show reduced asthma prevalence in high-risk infants.
  • Probiotics, education, and immunizations show some protective effects.

Conclusions:

  • Further research is needed on long-term follow-up of intervention studies.
  • Optimal timing and duration of interventions require investigation.
  • Novel approaches for primary prevention of pediatric asthma and allergies warrant exploration.
Abstract

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include: